3 Undervalued Biotechnology Stocks for Tuesday, October 08
Discover the top 3 undervalued Biotechnology stocks for Tuesday, October 08 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
AquaBounty Technologies, Inc. operates as a land-based aquaculture company. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.
Commentary & Analysis
4 Undervalued Biotechnology & Medical Research Stocks for Thursday, July 27
Discover the top 4 undervalued Biotechnology & Medical Research stocks for Thursday, July 27 based on AAII’s Stock Grades.Jack Gilleland
4 Undervalued Biotechnology & Medical Research Stocks for Monday, May 15
Discover the top 4 undervalued Biotechnology & Medical Research stocks for Monday, May 15 based on AAII’s Stock Grades.Jenna Brashear
Is Aquabounty Technologies Inc (AQB) Stock a Good Investment?
Learn more about Aquabounty Technologies Inc's (AQB) stock grades for Value, Momentum, Growth and Estimate Revisions and determine whether this Biotechnology & Medical Research stock meets your investment needs.Jack Gilleland
Financial Summary
| Share Statistics | AQB | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $5.4 | $218.1 | 4% |
|
| Shares Out (Mil) | 5.1 | 53.9 | 14% |
|
| Institutional Ownership | 94.8% | 93.1% | 66% |
|
| Float (Mil) | 5.1 | 40.9 | 12% |
|
| Beta | 1.40 | 0.95 | 79% |
|
| Avg Daily Volume (000s) | 74 | 611 | 32% |
|
| Price Change (52-week) |
(40.6%) | 46.3% | 24% |
|
| Growth | AQB | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 12.8% | na |
|
| Net Income (5yr) | (2.4%) | (10.2%) | 37% |
|
| EPS (5yr) | 12.0% | 15.7% | 51 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | (73.3%) | (15.7%) | 2% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | AQB | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($18) | ($44) | 24% |
|
| EPS (TTM) | ($4.201) | ($1.600) | 9% |
|
| Operating Cash Flow (TTM) (Mil) | ($7) | ($33) | 23% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | $6 | $177 | 6% |
|
| Valuation | AQB | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.89 | 2.13 | 51% |
|
| P/E | na | 19.3 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | AQB | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.0% | na |
|
| Net Margin | na | (75.3%) | na |
|
| ROA | (95.7%) | (47.2%) | 6% |
|
| ROE | (223.5%) | (54.2%) | 4% |
|
| Liabilities to Assets | 76.0% | 29.1% | 72% |
|
| F-Score | 2 | 3 | 7% |
|
AquaBounty Technologies, Inc. did not pass any screens on 10/14/2026.
